Daniela Campion

机构：University of Turin · ORCID：0000-0001-8782-1124

发表论文 69 篇 · 总被引 2808 次 · h-index 20

代表论文

• Simvastatin and Rifaximin in Decompensated Cirrhosis (2025 · JAMA · 被引 45)
• Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis (2023 · Gut · 被引 33)
• A prospective, multicenter, three-cohort study evaluating contrast-induced acute kidney injury (CI-AKI) in patients with cirrhosis (2023 · Journal of Hepatology · 被引 20)
• Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy (2022 · Current Oncology · 被引 18)
• Assessment of glomerular filtration rate in patients with cirrhosis: Available tools and perspectives (2022 · Liver International · 被引 15)
• Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial (2023 · Journal of Hepatology · 被引 12)